The global costs of Schizophrenia

Schizophrenia Bulletin

Volumn 30, Issue 2, 2004, Pages 279-293

  Knapp, Martin ^a   Mangalore, Roshni ^b   Simon, Judit ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Burden of illness; Cost of illness; Economics; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ABSENTEEISM; ARTICLE; COST OF ILLNESS; CRIMINAL JUSTICE; DRUG COST; EMPLOYABILITY; FAMILY LIFE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; MENTAL DISEASE; MENTAL HEALTH CARE; MORTALITY; PRIORITY JOURNAL; PRODUCTIVITY; PSYCHOSIS; SCHIZOPHRENIA;

EID: 1842858243     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007078     Document Type: Article

References (69)

1. Almond, S., and Healey, A. Mental health and absenteeism from work. Work, Employment and Society, 17(4):731-742, 2003.
2. Andrews, G. The cost of schizophrenia revisited. Schizophrenia Bulletin, 17(3):389-394, 1991.
3. Andrews, G.; Hall, W.; Goldstein, G.; Lapsley, H.; Bartels, R.; and Silove, D. The economic costs of schizophrenia: Implications for public policy. Archives of General Psychiatry, 42(6):537-543, 1985.
4. Arboledo-Florez, J.; Holley, H.J.; and Crisanti, A. Calgary World Health Organization Collaborating Centre for Research and Training in Mental Health. Mental Illness and Violence: Proof or Stereotype? Ottawa, Canada: Health Promotion and Programs Branch, Health Canada, 1996.
5. Birmingham, L.; Mason, D.; and Grubin, D. Prevalence of mental disorder in remand prisoners: Consecutive case study. British Medical Journal, 313:1521-1524, 1996.
6. Brooke, D.; Taylor, C.; Gunn, J.; and Maden, A. Point prevalence of mental disorder in unconvicted male prisoners in England and Wales. British Medical Journal, 313(7071):1524-1527, 1996.
7. Clark, R.E.; Xie, H.; Adarhi-Meija, A.M.; and Sergupta, A. Substitution between formal and informal care for persons with severe mental illness and substance use disorders. Journal of Mental Health Policy and Economics, 4(3):123-132, 2001.
8. Clark, R.E.D., and Drake, R.E.C. Expenditure of time and money by families of people with severe mental illness and substance use disorders. Community Mental Health Journal, 30(2):145-163, 1994.
9. Creed, F.; Mbaya, P.; Lancashire, S.; Tomenson, B.; Williams, B.; and Holme, S. Cost effectiveness of day and inpatient psychiatric treatment: Results of a randomised controlled trial. British Medical Journal, 314(7091):1381-1385, 1997.
10. Davies, L.M., and Drummond, M.F. Economics and schizophrenia: The real cost. British Journal of Psychiatry, 165(Suppl 25):18-21, 1994.
11. De Hert, M.; Thys, E.; Boydens, J.; Gilis, P.; Kesteloot, K.; Verhaegen, L.; and Peuskens, J. Health care expenditure on schizophrenia patients in Belgium. Schizophrenia Bulletin, 24(4):519-527, 1998a.
12. De Hert, M.; Thys, E.; and Peuskens, J. The costs of schizophrenia. Acta Psychiatrica Belgica, 98(Suppl 1):9-16, 1998b.
13. Der, G.; Gupta, S.; and Murray, R.M. Is schizophrenia disappearing? Lancet, I:513-516, 1990.
14. Druss, B.G.; Rosenheck, R.A.; Desai, M.M.; and Perlin, J.B. Quality of preventive medical care for patients with mental disorders. Medical Care, 40(2):129-136, 2002.
15. Evers, S.M.A.A., and Ament, A.J.H.A. Costs of schizophrenia in The Netherlands. Schizophrenia Bulletin, 21(1):141-153, 1995.
16. Fischer, W., and Barrelet, L. Les Couts des traitements psychiatriques: Une approche comparative de trois categories de patients. Medicine Sociale et Preventive, 32:168-175, 1987.
17. Foster, K.; Melzer, H.; Gill, B.; and Hinds, K. OPCS Surveys of Psychiatric Morbidity Report 8: Adults With a Psychiatric Disorder Living in the Community. London, UK: HMSO, 1996.
18. Franks, D.D. Economic contribution of families caring for persons with severe and persistent mental illness. Administration and Policy in Mental Health, 18:9-18, 1990.
19. Goeree, R.; O'Brien, B.J.; Goering, P.; Blackhouse, G.; Agro, K.; Rhodes, A.; and Watson, J. The economic burden of schizophrenia in Canada, Canadian Journal of Psychiatry, 44:464-472, 1999.
20. Guest, J.F., and Cookson, R.F. Cost of schizophrenia to U.K. society. Pharmacoeconomics, 15(6):597-610, 1999.
21. Gunderson, J.G., and Mosher, L.R. The cost of schizophrenia. American Journal of Psychiatry, 132:901-906, 1975.
22. Häfner, H.; Buchholz, W.; Bardens, R.; Krumm, B.; and an der Heiden, W. Organization, effectiveness and profitability of complementary health care of schizophrenic patients. Neurologist, 57:214-226, 1986.
23. Hall, W.; Andrews, G.; and Goldstein, G. The costs of schizophrenia. Australian and New Zealand Journal of Psychiatry, 19:3-5, 1985.
24. Haro, J.M.; Salvador-Carulla, L.; Cabases, J.; Mandox, V., and Vazquez-Barquero, J.L. Utilization of mental health services and costs of patients with schizophrenia in three areas of Spain. British Journal of Psychiatry, 173:334-340, 1998.
25. Harris, E.C.; and Barraclough, B. Excess mortality of mental disorder. British Journal of Psychiatry, 173:11-53, 1998.
26. Hertzman, P. The economic costs of mental illness in Sweden 1975. Acta Psychiatrica Scandinavica, 68:359-367, 1983.
27. Hu, T.W.; Shumway, M.; and Hargreaves, W.A. Estimating costs of schizophrenia and its treatment. In: Moscarelli, M.; Rupp, A.; and Sartorius, N., eds. Handbook of Mental Economics and Health Policy. Vol. 1. Chichester, U.K.: John Wiley and Sons, 1996. pp. 359-371.
28. Ige, A.O. Burden of psychiatric illness on the family. Thesis, West African Postgraduate Medical College, Lagos, 1993.
29. Jenkins, R. Minor psychiatric disorder in employed young men and women and its contribution to sickness absence. British Journal of Industrial Medicine, 42:147-154, 1985.
30. Johnstone, E.C.; Frith, C.D.; Leary, J.; Owens, D.G.C.; Wilkins, S.; and Hershon, H.I. Background, method and general description of the sample. British Journal of Psychiatry, 159 (Suppl 13):43-46, 1991.
31. Jönsson, D., and Walinder, J. The socio-economic cost of treatment of therapy refractory schizophrenic patients in Sweden. Nordic Journal of Psychiatry, 48:311-313, 1994.
32. Kavanagh, S.; Opit, L.; Knapp, M.; and Beecham, J. Schizophrenia: shifting the balance of care. Social Psychiatry and Psychiatric Epidemiology, 30:206-212, 1995.
33. Kessler, R.C.; Greenberg, P.E.; and Mickelson, K.D. The effects of chronic mental health conditions on work loss and work cut back. Journal of Occupational and Environmental Medicine, 43:218-225, 2001.
34. Kissling, W.; Hoffler, J.; Seemann, U.; Muller, P.; Ruther, E.; Trenckmann, U.; Uber, A.; Graf von der Schulenburg, J.M.; Glaser, P.; Glaser, T.; Mast, O.; and Schmidt, D. Die direkten und indirekten kosten der schizophrenie. Fortschritte der Neurologie-Psychiatrie, 67:29-36, 1999.
35. Knapp, M. Costs of schizophrenia. British Journal of Psychiatry, 171:509-515, 1997.
36. Langley-Hawthorne, C. Modelling the lifetime costs of treating schizophrenia in Australia. Clinical Therapeutics, 19(6):1470-1495, 1997.
37. Leslie, D.L., and Rosenheck, R. Shifting to outpatient care? Mental health care use and cost under private insurance. American Journal of Psychiatry, 156:1250-1257, 1999.
38. Lindstrom, E. The hidden cost of schizophrenia. Journal of Drug Development in Clinical Practice, 7(4):281-288, 1996.
39. Lund, P. "A Calculation of the Costs of Schizophrenia in Denmark." Paper presented at the A.R.C.A.P. Third Workshop on Costs and Assessment in Psychiatry, Venice, Italy, October 28-30, 1994.
40. Magliano, L.; Fadden, G.; Madianos, M.; de Almeida, J.M.; Held, T.; Guarneri, M.; Marasco, C.; Tosini, P.; and Maj, M. Burden on the families of patients with schizophrenia: Results of the BIOMED I study. Social Psychiatry and Psychiatric Epidemiology, 33(9):405-412, 1998.
41. Martin, B.C., and Miller, S. Expenditures for treating schizophrenia: A population-based study of Georgia Medicaid recipients. Schizophrenia Bulletin, 24(3):479-488, 1998.
42. Martyns-Yellowe, I.S. The burden of schizophrenia on the family: A study from Nigeria. British Journal of Psychiatry, 161:779-782, 1992.
43. Meerding, W.J.; Bonneux, L.; Polder, J.J.; Koopmanschap, M.A.; and van der Maas, P.J. Demographic and epidemiological determinants of health-care costs in Netherlands: Cost of illness study. British Medical Journal, 317:111-115, 1998.
44. Monahan, J., and Arnold, J. Violence by people with mental illness: A consensus statement by advocates and researchers. Psychiatric Rehabilitation Journal, 19:67-70, 1996.
45. Moscarelli, M.S.; Capri, S.; and Neri, L. Cost evaluation of chronic schizophrenic patients during the first three years after first contact. Schizophrenia Bulletin, 17(3):421-426, 1991.
46. Muller, C.F., and Caton, C.L.M. Economic costs of schizophrenia: A post-discharge survey. Medical Care, 21:92-104, 1983.
47. National Health Service Executive. Burdens of Disease. London, U.K.: Department of Health, 1996.
48. Osterheider, M.; Franken-Hiep, K.; and Horn, R. Gesamtkrankenkosten der Schizophrenie und monetare Bewertung einer Rezidivprophylaxe am Beispiel eines Standard-Depot-Neuroleptikums (Flupentixoldecanoat). Psychiatrische Praxis, 25:38-43, 1998.
49. Pang, F. Design, analysis and presentation of multinational economic studies; the need for guidance. Pharmacoeconomics, 20(2):75-90, 2002.
50. Pietzcker, A. Neuroleptische Langzeit-Medikation in der ambulanten Behandlung schizophren Kranken. Hamburg, Germany: Promonta Schriften, 1987.
51. Rascon, R.; Arredondo, A.; Tirado, L.; and Lopez, M. Una approximacion al costo del tratamiento de las enfermedades mentales en Mexico: Depresion y esquizofrenia. Salud Mental, 21(1):43-47, 1998.
52. Rice, D.P., and Miller, L.S. The economic burden of schizophrenia: Conceptual and methodological issues and cost estimates. In: Moscarelli, M.; Rupp, A.; and Sartorius, N., eds. Handbook of Mental Health Economics and Health Policy. Vol. 1. Chichester, U.K.: John Wiley and Sons, 1996.
53. Roberts, A.A. The labor market consequences of family illness. Journal of Mental Health Policy and Economics, 2(4):183-195, 1999.
54. Rouillon, F.; Toumi, M.; Dansette, G.Y.; Benyaya, J.; and Auquier, P. Some aspects of the cost of schizophrenia in France. Pharmacoeconomics, 11(6):578-594, 1997.
55. Rubio-Stipec, M.; Stipec, B.; and Canino, G. The costs of schizophrenia in Puerto Rico. Journal of Mental Health Administration, 21(2):136-144, 1994.
56. Rund, B.R. Schizofreni-hvor mye bruker vi pa behandling og forskning? (Schizophrenia: How much do we need for the cost of treatment and research?) Tidsskr Nor Laegeforen, 115:2682-2683, 1995.
57. Rund, B.R., and Ruud, T. Cost of services for schizophrenic patients in Norway. Acta Psychiatrica Scandinavica, 99:120-125, 1999.
58. Rupp, Á.; Harangozó, J.; Bognár, G.; Iván, N.; and Radó, I. A szkizofrénia gazdasági költségei Magyarországon az 1990es években. Psychiatria Hungarica, 14(2):131-142, 1999.
59. Salize, H.J., and Rössler, W. The cost of comprehensive care of people with schizophrenia living in the community: A cost evaluation from a German catchment area. British Journal of Psychiatry, 169:42-48, 1996.
60. Sartorius, N.; Fleischhacker, W.; Gjerris, A.; Kern, U.; Knapp, M.; Leonard, B.; Lieberman, J.; José Lopez-Ibor, J.; van Raay, B.; and Twomey, E. The usefulness of and use of second-generaion antipsychotic medications: Review of evidence and recommendations by a Task Force of the World Psychiatric Association. Current Opinion in Psychiatry, 15(Suppl 1):S1-S51, 2002.
61. Skarbek, K.S., and Koval, A. "Burden of schizophrenia in Poland: Report of the Phare Action for Cooperation in the field of Economics Programme." Unpublished manuscript, 1999.
62. Suleiman, T.G.; Ohaeri, J.U.; Lawal, R.A.; Haruna, A.Y.; and Orija, O.B. Financial cost of treating out-patients with schizophrenia in Nigeria. British Journal of Psychiatry, 171:364-368, 1997.
63. Tarricone, R.; Gerzeli, S.; Montanelli, R.; Frattura, L.; Percudani, M.; and Racagni, G. Direct and indirect costs of schizophrenia in community psychiatric services in Italy: The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. Health Policy, 51(1):1-18, 2000.
64. Taylor, P., and Gunn, J. Homicides by people with mental illness: Myth and reality. British Journal of Psychiatry, 174:9-14, 1999.
65. Terkelsen, K.G., and Menikoff, A. Measuring the costs of schizophrenia. Pharmacoeconomics, 8(3):199-222, 1995.
66. Warner, R., and de Girolamo, G. Epidemiology of Mental Disorders and Psychosocial Problems. Geneva, Switzerland: World Health Organization, 1995.
67. Wiersma, D.; Kluiter, H.; Neinhuis, F.J.; Ruphan, M.; and Giel, R. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders. British Journal of Psychiatry, Supplement, 166(Suppl. 27):52-59, 1995.
68. Wistedt, B. In: Michels, R., ed. The Cost of Schizophrenia. London, U.K.: Royal Society of Medicine Services, 1992. pp. 3-5.
69. Wyatt, R.J.; Henter, I.; Leary M.C.; and Taylor, E. An economic evaluation of schizophrenia-1991. Social Psychiatry and Psychiatric Epidemiology, 30:196-205, 1995.